Article
Investigation of Anti-Epithelial-Mesenchymal Transition and Anti-Inflammation effects of Qing Fei Hua Xian Decotion on Pulmonary Fibrosis via Network Pharmacology and Experimental Verification
2022-06-09
Abstract excerpt
<title>Abstract</title> <p>Background Pulmonary fibrosis (PF) is a common interstitial pneumonia disease, also occurred in post-COVID-19 survivors. The mechanism underlying the anti-PF effect of Qing Fei Hua Xian Decotion (QFHXD), a traditional Chinese medicine formula applied for treating PF in COVID-19 survivors, is unclear. This study aimed to uncover the mechanisms related to the anti-PF effect of QFHXD thro...
Topics
Open a Topic to create a Post that cites this publication.
- Asthma and respiratory diseases
- Cancer-related molecular mechanisms research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Computational Drug Discovery Methods
- Inflammasome and immune disorders
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Metabolomics and Mass Spectrometry Studies
Identifiers and source
- Literature Corpus work
- 980d8058-df1e-5bc5-9743-bf53ce33a28e
- DOI
- 10.21203/rs.3.rs-1663242/v1
